Pharma and Biotech
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-25 | 82.60 | 1.40 | 13.71p | 1.7 | n/a | n/a | n/a | 0.0% |
30-Sep-26 | 86.25 | 10.85 | 1.20p | 19.8 | n/a | -91% | n/a | 0.0% |
30-Sep-27 | 94.45 | 12.20 | 1.60p | 14.9 | 0.4 | +33% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Current | 1 week ago | 1 month ago | 3 months ago | 6 months ago | 1 year ago | |
---|---|---|---|---|---|---|
Revenue (£m) | ||||||
30-Sep-2025 | 83 | 83 | 83 | 83 | 171 | 201 |
30-Sep-2026 | 86 | 86 | 86 | 86 | 192 | 225 |
30-Sep-2027 | 94 | 94 | 94 | 94 | n/a | n/a |
Earnings | ||||||
30-Sep-2025 | 13.71p | 13.71p | 13.71p | 13.71p | 1.00p | 0.25p |
30-Sep-2026 | 1.20p | 1.20p | 1.20p | 1.20p | 1.70p | 1.70p |
30-Sep-2027 | 1.60p | 1.60p | 1.60p | 1.60p | n/a | n/a |
Dividend | ||||||
30-Sep-2025 | n/a | n/a | n/a | n/a | n/a | n/a |
30-Sep-2026 | n/a | n/a | n/a | n/a | n/a | n/a |
30-Sep-2027 | n/a | n/a | n/a | n/a | n/a | n/a |
Recommendations | ||||||
Strong Buy | 1 | 0 | 1 | 1 | 0 | 0 |
Buy | 1 | 0 | 1 | 1 | 1 | 1 |
Neutral | 0 | 0 | 0 | 0 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Brokers | 2 | 0 | 2 | 2 | 2 | 2 |
Average Rec | 8.75 | n/a | 8.75 | 8.75 | 6.25 | 6.25 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 23.80p |
Change Today | 1.80p |
% Change | 8.18 % |
52 Week High | 45.85 |
52 Week Low | 17.70 |
Volume | 2,445,829 |
Shares Issued | 741.51m |
Market Cap | £176.48m |
Beta | 0.02 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
13:13 | 4,131 @ 23.80p |
13:13 | 55,387 @ 23.80p |
13:13 | 132,113 @ 23.80p |
12:36 | 33,333 @ 23.80p |
11:32 | 30,000 @ 23.75p |
CFO | Septima Maguire |
CEO | Trond Williksen |
Chair | Tripp Lane |
You are here: research